Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products... Show more
LFVN is expected to report earnings to rise 30.56% to 23 cents per share on February 03
Q4'25
Est.
$0.23
Q3'25
Missed
by $0.03
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.06
Q4'24
Beat
by $0.08
The last earnings report on November 04 showed earnings per share of 18 cents, missing the estimate of 20 cents. With 94.14K shares outstanding, the current market capitalization sits at 82.05M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LFVN showed earnings on November 04, 2025. You can read more about the earnings report here.